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Opening Remarks
Overview
 2016 Zika Lessons Learned
 Updates to Zika Guidance
 Task Force Recommendations for Jurisdictional and CDC Actions for 2017
 Q&As
 Closing Remarks
Pregnancy and Birth Defects Task Force
1) US Zika Pregnancy Registry (USZPR)
2) Clinical Guidance
3) Zika Birth Defects Surveillance
4) Zika Active Pregnancy Surveillance System (ZAPSS) in Puerto Rico
5) Contraception Access
6) Colombia Collaboration with Instituto Nacional de Salud (INS)
PBDTF Primary Projects
The Difference a Year Makes
February 2016
What did we want to know?
• Does Zika cause microcephaly and other birth 
defects?
• Are fetuses of asymptomatic pregnant women also 
at risk for congenital Zika syndrome?
What were we doing to learn more and 
protect pregnant women and infants?
• Zika pregnancy registries and birth defects 
surveillance
What guidance was available for healthcare 
providers?
• 3 clinical guidance MMWRs
The Difference a Year Makes
What do we know now?
• Zika during pregnancy is a cause of microcephaly, serious 
brain abnormalities, and potentially other birth defects
• Clinical phenotype defined for congenital Zika syndrome
How many pregnant women are being monitored?
Rapid birth defects surveillance in 50 US jurisdictions includes:
• > 4,700 pregnant women with Zika in all US states and 
territories in surveillance
• > 1,200 pregnant women with Zika in Colombia in surveillance
What guidance is now available for healthcare 
providers?
• 9 clinical guidance MMWRs and 5 HANs; new 
recommendations for areas with past or likely transmission
February 2016 February 2017
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• Does Zika cause microcephaly and other birth 
defects?
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at risk for congenital Zika syndrome?
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Building the Evidence Base
Clinical Guidance Documents9





On March 10, 2017, CDC updated its travel guidance:
Pregnant women should not travel to any area with a risk of Zika
Areas with risk of Zika and CDC travel 
notice: Pregnant women should be tested 
for Zika, regardless of whether or not they 
have symptoms.
Areas with Zika risk but no CDC Zika travel notice: 
Pregnant women should be tested if symptomatic or if their 
fetus has abnormalities on an ultrasound that may be 
related to Zika infection. Because the level of risk of Zika 
virus infection is unknown in these areas, routine testing is 
not recommended for pregnant women who have traveled 
to those areas but who do not have symptoms. However, 
testing may be offered on a case-by-case basis. 
Updated Guidance: Testing for Pregnant Women
For exposure in the United States, visit CDC’s 
website for current maps and guidance.
If the female partner was exposed to this area*, wait at least 8 
weeks after the last possible exposure or after symptoms start (if 
she developed symptoms) before trying to conceive. During this 
waiting period, use condoms or do not have sex.
Areas with Zika risk but no CDC Zika travel notice: 
If the male partner was exposed to this area*, wait at least 6 
months after the last possible exposure* or after symptoms start 
(if he developed symptoms) before trying to conceive. During this 
waiting period, use condoms or do not have sex.
Updated Guidance: Couples Trying to Conceive
Areas with risk of Zika and CDC travel notice:
Because the level of risk in this area is unknown and information is 
limited about the risk of infection around the time of conception, 
couples should talk with their healthcare provider about plans for 
pregnancy, travel plans, risk of Zika virus infection, the possible 
health effects of Zika virus infection on a baby, and ways to 
prevent Zika.
Ongoing Zika Activities
US Zika Pregnancy 
Registry
Zika Active Pregnancy 
Surveillance System 
(Puerto Rico) 
Proyecto Vigilancia de 
Embarazadas con Zika 
(Colombia)
US Zika-Related Birth 
Defects Surveillance
Pregnancy and Birth Defects Surveillance for Zika
Collecting Data To Inform Public Health Recommendations
Salt Lake County Health Dept
Alameda County Public Health Dept
County of San Diego Health and Human Services
City of El Paso Dept of Health
FL Dept of Health – Miami-Dade County
City of Laredo Dept of Health
Hidalgo County Health and 
Human Services Dept








OutreachFL Dept of Health – Palm Beach County
FL Dept of Health – Orange County
USVI Dept of Health
Fairfax County Health Dept
District of Columbia Dept of Health
Chicago Dept of Public Health
Kane County Health Dept
Kosrae/Micronesia Dept of 
Health Services
Local Health Department (LHD) Initiative
Two program components:
1. Provider Network for Families Affected by Zika
Identify specialty healthcare providers (1,200 providers in network initially)
• Maternal-fetal medicine, pediatric neurology, pediatric ophthalmology, pediatric radiology, 
audiology, mental health services, early intervention services, developmental pediatrics, 
physical therapy, and occupational therapy
• Planned expansion in mid-2017
2. Laboratory Testing Web Portal for Healthcare Providers
Identify laboratories that can test for Zika
Zika Care Connect will be accessible via website and HelpLine, hosted in collaboration with 
the March of Dimes, and will launch in April 2017.
Zika Care Connect: Improving Access to Clinical Services
To support increasing access to contraception for women and couples 
who live in areas with risk of Zika and who want to delay or avoid 
becoming pregnant:
Increasing Access To Contraception





CDC’s Key Priorities to Address Zika in 2017
Selected Priorities for Continued Surveillance
• Monitoring the frequency of Zika infections in pregnant women in the 
US
• Understanding the effect of Zika on birth defects consistent with 
congenital Zika infection
• Identifying the full range of disabilities linked to congenital Zika 
infection
Continue to Update Guidance for Healthcare Providers, 
Pregnant Women, Reproductive Age Couples, and Families
Update and disseminate new guidance 
Provide educational and public health tools
Continue to engage with STLT health officials, healthcare 



















































Educational Tools: HCPs Caring for Infants




























• What do you see is the greatest need for 2017?
• What are barriers in testing pregnant women and infants in your jurisdiction?
• What challenges do you face in collecting data for the US Zika Pregnancy Registry or 
Birth Defects Surveillance? 
• What has helped? 
• What are barriers to timely reporting?
• What are the unmet needs for clinical services for affected families?





For more information, contact CDC  
1-800-CDC-INFO (232-4636)
TTY: 1-888-232-6348 www.cdc.gov
The findings and conclusions in this report are those of the authors and do not necessarily represent the  
official position of the Centers for Disease Control and Prevention.
Thank You!
